On November 10, 2021 Wugen, Inc., a clinical-stage biotechnology company developing a pipeline of off-the-shelf cell therapies to treat a broad range of hematological and solid tumor malignancies, reported that management will participate in the upcoming Virtual Jefferies London Healthcare Conference set to take place November 16 – 19, 2021 (Press release, Wugen, NOV 10, 2021, View Source [SID1234595059]). The presentation will be available to registered conference attendees for on-demand viewing on Thursday, November 18 at 8:00 a.m. GMT (3:00 a.m. ET).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!